Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Determination of Absorption and Elimination of Lamotrigine-XR

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by University of Minnesota - Clinical and Translational Science Institute.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00789113
First received: November 7, 2008
Last updated: February 26, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2011
  Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)